ADMA Biologics, Inc. (ADMA)

ADMA Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	90.29	103.15	51.35	86.52	51.09	55.92
Cash & Short-Term Investments	90.29	103.15	51.35	86.52	51.09	55.92
Cash Growth	2.31%	100.86%	-40.65%	69.36%	-8.64%	109.03%
Receivables	109.73	50	27.42	15.51	28.58	13.24
Inventory	191.46	170.24	172.91	163.28	124.72	81.54
Prepaid Expenses	8.09	8.03	5.33	5.1	4.34	3.05
Total Current Assets	399.56	331.41	257.01	270.4	208.73	153.74
Property, Plant & Equipment	66.46	63.34	63.47	68.75	58.2	45.85
Goodwill	3.53	3.53	3.53	3.53	3.53	3.53
Other Intangible Assets	0.53	0.46	0.5	1.01	1.73	2.44
Long-Term Deferred Tax Assets	79.24	84.28	-	-	-	-
Other Long-Term Assets	9.06	5.66	4.67	4.77	4.07	2.11
Total Assets	558.38	488.68	329.18	348.46	276.25	207.67
Accounts Payable	29.77	20.22	15.66	13.23	12.43	11.07
Accrued Expenses	23.71	28.63	30.55	23.19	16.23	8.16
Current Portion of Leases	1.13	1.22	1.05	0.91	0.59	0.37
Current Income Taxes Payable	2.7	3.48	-	-	-	-
Current Unearned Revenue	0.14	0.14	0.18	0.14	0.14	0.14
Other Current Liabilities	17.49	1.85	2.37	1.8	0.98	0.21
Total Current Liabilities	74.94	55.54	49.81	39.27	30.38	19.95
Long-Term Debt	73.4	72.34	130.59	142.83	94.87	92.97
Long-Term Leases	9.3	8.56	9.78	10.7	7.46	4.33
Long-Term Unearned Revenue	1.48	1.55	1.69	1.83	1.98	2.12
Other Long-Term Liabilities	0.94	1.67	2.11	1.85	0.4	0.05
Total Liabilities	160.06	139.66	193.98	196.49	135.08	119.42
Common Stock	0.02	0.02	0.02	0.02	0.02	0.01
Additional Paid-In Capital	660.91	657.58	641.44	629.97	553.27	428.7
Retained Earnings	-247.46	-308.58	-506.26	-478.02	-412.11	-340.47
Shareholders' Equity	398.33	349.02	135.21	151.97	141.17	88.25
Total Liabilities & Equity	558.38	488.68	329.18	348.46	276.25	207.67
Total Debt	83.83	82.12	141.42	154.44	102.92	97.67
Net Cash (Debt)	6.46	21.03	-90.07	-67.92	-51.83	-41.75
Net Cash Per Share	0.03	0.09	-0.40	-0.34	-0.37	-0.48
Filing Date Shares Outstanding	238.63	237.62	228.22	222.16	195.92	121.28
Total Common Shares Outstanding	238.57	236.62	226.06	221.82	195.81	104.9
Working Capital	324.62	275.87	207.21	231.14	178.35	133.79
Book Value Per Share	1.67	1.48	0.60	0.69	0.72	0.84
Tangible Book Value	394.27	345.03	131.18	147.43	135.91	82.28
Tangible Book Value Per Share	1.65	1.46	0.58	0.66	0.69	0.78
Land	4.34	4.34	4.34	4.34	4.34	4.34
Buildings	25.48	21.79	20.22	19.54	19.07	17.4
Machinery	39.97	32.92	32.93	29.2	24.17	20.11
Construction In Progress	4.1	8.15	2.27	6.73	5.5	3.34
Leasehold Improvements	21.14	21.07	20.81	17.93	11.13	5.27

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q